3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
9
Observational
1
Sponsor
Cancer Type
Gastrointestinal
42
Thoracic
1
Other neoplasm
1
Gynecologic
1
Breast
1
Conditions
Breast Neoplasms
2934
Neoplasms
174
Lung Neoplasms
149
Prostatic Neoplasms
116
Ovarian Neoplasms
113
Colorectal Neoplasms
106
Triple Negative Breast Neoplasms
98
Colonic Neoplasms
91
Neoplasm Metastasis
74
Melanoma
66
Carcinoma, Non-Small-Cell Lung
64
Pancreatic Neoplasms
63
Carcinoma, Intraductal, Noninfiltrating
60
Stomach Neoplasms
54
Head and Neck Neoplasms
47
Breast Cancer Female
45
Lymphedema
42
Uterine Cervical Neoplasms
40
Breast Carcinoma In Situ
35
Esophageal Neoplasms
34
Cardiotoxicity
34
Urinary Bladder Neoplasms
33
Motor Activity
33
Lymphoma
33
Endometrial Neoplasms
33
Breast Diseases
33
Fatigue
30
Rectal Neoplasms
28
Breast Neoplasms, Male
28
Multiple Myeloma
27
Interventions
Polymerase Chain Reaction
1
Mass Spectrometry
1
In Situ Hybridization, Fluorescence
1
Immunohistochemistry
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Adenocarcinoma Of Esophagus
×
Breast
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled